The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing

ConclusionNASM-PCR as a rapid genetic test holds promise for personalizing antiplatelet therapy in Asian CCS patients.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research